EnvisionOne Insights: Transforming data management in life sciences
The company says this new data and analytics management solution marks a significant shift in how medical affairs professionals can access, manage, and optimize complex data. The launch of the new platform is a foundational moment for the company, harnessing the power of big data to enhance decision-making and improve patient outcomes.
It is designed to unify complex data into one comprehensive repository, allowing seamless movement and accessibility across Envision’s suite of technologies, including the widely used iEnvision platform and this emerging platform. This integration enables medical affairs professionals to make evidence-based decisions with greater efficiency by eliminating manual processes and streamlining data management.
Also notable, the company says, is that it is the first solution launched on Envision Pharma Group's next-generation SaaS framework, the platform. It says the platform is set to revolutionize how life sciences companies handle their data. A future module, expected to be available in late 2024, will offer advanced features such as predictive analytics, machine learning, and artificial intelligence, delivering an end-to-end solution throughout the product lifecycle.
Jim Streeter, president of technology and chief technology officer at Envision Pharma Group said: “Our strategy is based on the convergence of data and insights to help clients make faster, smarter decisions. EnvisionOne Insights draws on many layers of data in our legacy system, providing a whole new level of insights to clients by improving the accessibility of data in a single unified model."
Streeter adds, “This offers a new data paradigm, enabling us to work with data in our system we haven’t previously had access to, creating new intelligence capabilities and analytics expertise. Envision is now offering not just a technology, but a whole new level of insights to power up medical affairs analysis.”
Advanced data management capabilities
One of the key advantages of the platform, the company says, is its ability to provide simplified, secure access to structured data sets. By centralizing all data in one platform, the solution streamlines data management processes while enabling real-time integration for accessible reporting and insights. This allows professionals to create customizable reports and dashboards using powerful data visualization tools such as Power BI and APIs. Additionally, users have access to customizable templates, facilitating the extraction of actionable insights.
EnvisionOne Insights is set to further transform medical affairs by offering advanced data management capabilities. The platform will act as a crucial conduit, channeling data through AI and predictive analytics, allowing for more informed decision-making processes. This next-level integration of human agency and advanced analytics will enable medical affairs professionals to uncover impactful findings from their data, driving better patient outcomes.
The platform also draws on over 20 years of historical data, allowing users to tap into past intelligence while gaining real-time insights into emerging trends. By turning historical data into future success, the platform ensures that medical affairs professionals are equipped to handle the evolving needs of the industry.
Importantly, it addresses a long-standing need within the pharmaceutical industry for standardized and connected data systems. By eliminating manual data processes and optimizing efficiencies, the platform enables evidence-based decision-making that can positively affect patient outcomes. The best part, the company explains is the tool is available at no additional cost to existing Envision Pharma customers.
As the life sciences industry continues to evolve, the company says its new platform is positioned to be a game-changer in data and analytics management for medical affairs. The solution empowers professionals with the tools they need to access and analyze data more effectively, enabling faster, smarter decision-making in an increasingly complex field.
